Skip to main content

Rectal Cancer

Recurrent and Pelvic Rectal Cancer

Restaging, salvage surgery, pelvic exenteration, and realistic goals

Recurrence may appear in the pelvis or at the anastomosis after rectal cancer surgery or chemoradiation. Restaging with MRI, PET-CT, and endoscopy precedes any salvage plan. When tumor involves adjacent pelvic organs, pelvic exenteration may be discussed — but only in highly selected patients at experienced centers.

Pelvic recurrence does not automatically mean pelvic exenteration. When disease is not resectable, systemic therapy, radiation, or palliative pathways are discussed. Exenteration carries high morbidity — informed consent, stoma planning, and reconstruction are part of the same conversation.

Recurrent pelvic rectal cancer · educational illustration

Where recurrence appears

Common sites include the anastomosis, presacral space, pelvic sidewall, and perineum. Prior radiation slows tissue healing; imaging must distinguish recurrence from post-treatment change.

Restaging work-up

Pelvic MRI, contrast CT, PET-CT when selected, endoscopy, and CEA / CA 19-9 trends are reviewed together. Distant metastases usually change or exclude pelvic salvage surgery.

  • Pelvic MRI for local extent
  • CT / PET-CT for distant disease
  • Endoscopy for luminal involvement
  • Markers and prior pathology

Salvage surgical options

Limited recurrence may be treated with salvage TME, APR, or presacral resection. When tumor invades adjacent organs (bladder, uterus / prostate, vagina, levator, sacrum) and there is no unresectable distant disease, multi-organ pelvic exenteration may be discussed. Morbidity is higher after prior radiation; flap reconstruction and ICU planning are often required.

What is pelvic exenteration?

Pelvic exenteration is extensive salvage surgery removing the rectum together with involved pelvic organs en bloc. Anterior exenteration removes rectum with bladder (and in women uterus / ovaries, in men prostate); urine is usually managed with a permanent urostomy (ileal conduit) or, in selected patients, neobladder reconstruction. Posterior exenteration may include sacrum / coccyx resection with rectal removal. Total (supralevator) pelvic exenteration covers both anterior and posterior compartments — the widest indication and highest morbidity.

  • Anterior: rectum + bladder (± uterus / prostate)
  • Posterior: rectum + sacrum / coccyx resection
  • Total: multi-compartment, narrow indication
  • Permanent colostomy is almost always required

Who may be a candidate?

Decisions belong at the tumor board. Good performance status, no unresectable distant metastases, a single pelvic field, and radiologically clear margins are baseline requirements. Widespread peritoneal disease, major vessel involvement, or unresectable margins usually exclude surgery. The goal is not miracle salvage for everyone — in selected patients it is local control and symptom relief.

After exenteration and reconstruction

Permanent colostomy is standard. When the bladder is removed, urology plans urostomy or selected neobladder reconstruction. Perineal defects may need flap closure (VRAM, gracilis, etc.); prior radiation slows wound healing. Plastic surgery, urology / gynecology, ICU care, and early rehabilitation are planned together.

When disease is not resectable

Systemic therapy, re-irradiation in selected cases, endoscopic / local approaches, and symptom-focused palliation are realistic paths. Not every recurrence leads to heroic salvage surgery.

Common questions

  • Does recurrence always need surgery?
    Tap for details

    No. Distant metastases, extensive pelvic disease, or high operative risk favor systemic or palliative pathways.

  • What is pelvic exenteration?
    Tap for details

    Removal of the rectum with selected adjacent pelvic organs (bladder, uterus / prostate, etc.) en bloc in highly selected salvage cases. Types include anterior, posterior, and total exenteration — high morbidity, narrow indication.

  • Is a permanent stoma always needed after exenteration?
    Tap for details

    A permanent colostomy is standard. If the bladder is removed, a urostomy or selected urinary reconstruction is also planned. This is discussed in detail before surgery.

  • Is recurrence after watch-and-wait different?
    Tap for details

    Local recurrence after organ preservation is also planned at the tumor board; salvage surgery or non-operative routes are individualized.

Evidence

Scientific sources

Show sources · 3

Core guidelines for restaging and salvage pathways in recurrent pelvic rectal cancer.

  1. 1. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upESMO · 2017 (güncellemeler için ESMO GI portalına bakın) · DOI: 10.1093/annonc/mdx224Open source →
  2. 2. NCCN Clinical Practice Guidelines in Oncology: Rectal CancerNCCN · Güncel sürüm / Current versionOpen source →
  3. 3. ASCRS clinical practice guidelines libraryAmerican Society of Colon & Rectal Surgeons (ASCRS) · Kılavuz kütüphanesi / Guideline libraryOpen source →

Last reviewed: 21 August 2026. Links go to publisher pages.

Bu içerik bilgilendirme amaçlıdır; tıbbi tavsiye yerine geçmez. TNT, watch-and-wait ve cerrahi kararları evreleme, MR bulguları ve tümör konseyi ile kişiye özel verilir.

Türkçe sürüm